Perrigo Co. PLC faces a somewhat unfamiliar challenge of having competition from the start in its upcoming launch of an OTC private label version of Nexium24HR. But with its experience and reputation in private label products, it should seize the top spot among generics of the OTC treatment frequent heartburn and drive its consumer business sales.
Perrigo announced Aug. 21 that FDA granted final approval for its abbreviated new drug application for a store brand OTC...




